Skip to content
HowShorted

Emergent Biosolutions, Inc. short interest in 2025

In 2025, Emergent Biosolutions, Inc.'s disclosed short interest ran from 12.99% of shares outstanding on 15 Jan 2025 to 17.37% on 31 Dec 2025, a change of +4.38 percentage points. The year's high was 18.65% on 31 Jul 2025 and its low 12.78% on 31 Jan 2025, averaging 16.10% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 12.15 days on 31 Dec 2025. Full history: Emergent Biosolutions, Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for Emergent Biosolutions, Inc. in 2025

2025 in figures

Start of year
12.99% (15 Jan 2025)
End of year
17.37% (31 Dec 2025)
Change
+4.38 pp
High
18.65% (31 Jul 2025)
Low
12.78% (31 Jan 2025)
Average
16.10%
Highest days to cover
12.15 (31 Dec 2025)
SEC filings marked
8

Every report in 2025

Emergent Biosolutions, Inc. short interest in 2025
SettlementShort interestDays to coverFilings since previous
15 Jan 202512.99%7.12
31 Jan 202512.78%7.02
14 Feb 202513.09%8.72
28 Feb 202515.02%5.80
14 Mar 202516.90%5.22results (8-K), 10-K filed
31 Mar 202516.56%7.20
15 Apr 202516.66%7.45
30 Apr 202514.29%7.79
15 May 202514.58%5.45results (8-K), 10-Q filed
30 May 202514.43%5.66
13 Jun 202514.72%9.30
30 Jun 202518.44%5.45
15 Jul 202516.69%8.06
31 Jul 202518.65%9.43
15 Aug 202518.40%5.62results (8-K), 10-Q filed
29 Aug 202516.33%8.39
15 Sep 202516.60%9.17
30 Sep 202518.01%9.31
15 Oct 202516.55%10.20
31 Oct 202515.65%5.17results (8-K), 10-Q filed
14 Nov 202517.63%7.55
28 Nov 202516.98%10.86
15 Dec 202517.18%10.42
31 Dec 202517.37%12.15

See also: Emergent Biosolutions, Inc.'s full history · most shorted US stocks of 2025 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.